TAIPEI: A major Taiwanese Buddhist group said on Wednesday (Jul 21) it had signed a deal to buy 5 million doses of BioNTech’s COVID-19 vaccine via the German firm’s Chinese sales agent, further boosting the island’s fight against the pandemic.
The Tzu Chi Foundation said in June it was bidding to get the vaccines, and Taiwan’s government said it would allow the group to negotiate on its behalf for the shot. The vaccines will be donated to the government for distribution.
READ: Taiwan Buddhist group enters fray for Pfizer-BioNTech COVID-19 vaccines
In a statement on its Facebook page, Tzu Chi said it had signed the deal with a Hong Kong subsidiary of Fosun.
“After successfully signing the vaccine procurement contract, all the purchased vaccines will be donated to the competent authority for use by the public,” it added, without saying when the vaccines would arrive.
Neither BioNTech nor Fosun immediately responded to requests for comment.
Taiwan’s government expressed its thanks to Tzu Chi.
The news follows a combined 10 million-dose purchase by two Taiwanese tech firms, TSMC and Foxconn plus Foxconn founder Terry Gou’s charity, of the same vaccine earlier in July.
Taiwan allowed the companies and Tzu Chi to negotiate for the BioNTech vaccine following public pressure that the pace of vaccinations was too slow.
BioNTech developed the vaccine with Pfizer but Pfizer cannot directly sell it to Taiwan as BioNTech signed that right over to Fosun.
Taiwan’s government has millions of vaccines on order, while the United States and Japan have donated close to 6 million doses of the Moderna and AstraZeneca shots.
About 20 per cent of Taiwan’s 23.5 million people have received at least one of the two-shot vaccine regimen, and the government is ramping up its inoculation programme.
Taiwan has accused China, which claims the island as its own territory, of blocking a direct order from BioNTech this year. Beijing denies that.
BOOKMARK THIS: Our comprehensive coverage of the COVID-19 pandemic and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram